General Catalyst Group Management, LLC
Q4 2025 13F Holdings
- Locationcambridge, MA
- Num holdings
7
- Value ($000)
$221,741
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001637946
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SAMSARA INC | COM CL A | 79589L106 | $70.9M | 32 % | 2,000,000 | ||
MAZE THERAPEUTICS INC | COM | 578784100 | $42.92M | 19 % | 1,035,910 | ||
GITLAB INC | CLASS A COM | 37637K108 | $34.58M | 16 % | 921,405 | ||
MAPLEBEAR INC | COM | 565394103 | $31.97M | 14 % | 710,711 | ||
ARRIVENT BIOPHARMA INC | COM | 04272N102 | $30.08M | 14 % | 1,494,786 | ||
FRACTYL HEALTH INC | COM | 35168W103 | $10.75M | 5 % | 4,884,193 | ||
FIGMA INC | CLASS A COM STK | 316841105 | $554.76K | 0 % | 14,845 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100